Consolidated Statements of Cash Flows

QIAGEN Key figures 2012

 

  • Main Image Navi
Years ended December 31 (in thousands) 2015 2014
Cash flows from operating activities:     
Net income $ 126,857
$ 117,202
Adjustments to reconcile net income to net cash provided by operating activities, net of effects of businesses acquired:
 
 
Depreciation and amortization 191,473
200,782
Non-cash impairments  5,471
34,297
Amortization of debt discount and issuance costs 19,955 15,392
Share-based compensation expense 27,565
42,188
Excess tax benefits from share-based compensation (3,328)
(1,596)
Deferred income taxes (37,194)
(41,291)
Loss on early redemption of debt  7,564                                                   4,560
Loss on marketable securities  6,039                                                   3,914
Changes in fair value of contingent consideration    (5,225)
(1,165)
Other items, net 2,609
(7,509)
Net changes in operating assets and liabilities:
 
 
Accounts receivable (24,764)
(16,561)
Inventories (33,194)
(41,972)
Prepaid expenses and other 52,315
(2,273)
Other long-term assets 2,730
(13,090)
Accounts payable 7,732
(5,495)
Accrued and other liabilities (25,570)
(21,482)
Income taxes (88)
16,034
Other long-term liabilities (3,450)
5,850
Net cash provided by operating activities 317,497
287,965
Cash flows from investing activities:     
Purchases of property, plant and equipment (97,778)
(86,591)
Proceeds from sale of equipment 103
35
Purchases of intangible assets (19,703)
(10,412)
Purchase of investments (6,053)
(9,426)
Purchases of short-term investments (317,570)
(420,158)
Proceeds from sales of short-term investments 367,714
275,779
Cash paid for acquisitions, net of cash acquired (66,930)
(160,436)
Other investing activities (5,983) 3,608
Net cash used in investing activities (146,200)
(407,601)
Cash flows from financing activities:     
Purchase of call option related to cash convertible notes      (105,170)
Proceeds from issuance of warrants, net of issuance costs  68,900 
Net proceeds from issuance of cash convertible notes and cash paid for issuance costs  (86)  716,967 
Repayment of long-term debt (251,868)
(387,050)
Principal payments on capital leases (1,079)
(4,579)
Proceeds from subscription receivables 97
536
Excess tax benefits from share-based compensation 3,328
1,596
Proceeds from issuance of common shares 10,316
12,131
Purchase of treasury shares  (20,818) (126,889)
Other financing activities 1,497
16,401
Net (used in) provided by financing activities (258,613)
192,843
Effect of exchange rate changes on cash and cash equivalents (15,340)
(10,843)
Net (decrease) increase in cash and cash equivalents (102,656)
62,364
Cash and cash equivalents, beginning of year 392,667
330,303
Cash and cash equivalents, end of year $290,011 
$ 392,667
Supplemental cash flow disclosures:
 
 
Cash paid for interest $20,799
$ 24,052
Cash paid for income taxes $34,441
$ 12,539
Supplemental disclosure of non-cash investing and financing activities:
 
 
Equipment purchased through capital lease $231
$ 342
Intangible assets acquired in non-monetary exchange $5,900 $ -